Industry Symposia

Friday, August 13

  • Moderator: Dr. Diego Jaimes (COL)
  • Long-Term Outcomes with Baricitinib in RA. Dr. Mario Cardiel (MEX)
  • Real Life Evidence with Baricitinib. Dra. Rina Neubrath (BRA)
  • Moderator: Dr. Wilson Bautista (COL)
  • New treatment options for the patient with PsA. Dr. Diego Jaimes (COL)
  • From theory to practice: A clinical case of PsA. Dr. Valderilio Azevedo (BRA)
  • Chairman: Dr. Juan Moreno (Argentina)
  • How I treat rheumatoid arthritis (Prof. Josef Smolen) – 30 min
  • A practical approach considering Latin American reality: a debate (Prof. Josef Smolen, Prof. Eduardo Mysler, Prof. Morton Scheinberg) – 30 min
  •  
  • 2021: The odyssey of the IL-23 pathway in early PsA (15 min). Dr. Dennis McGonagle (UK)
  • Sharpening the tools: Role of US and MRI in the management of PsA in the clinical setting (15 min) Dr. Mikkel Ostergaard (Denmark)
  • Putting imaging to practice with a focus on US: the current picture (15 min). Dr. Alen Zabotti (Italy)
  • Q&As

Saturday, August 14

  • Welcome and introduction (5 min)– Dr Fernando Sommerfleck
  • Does the JAK-STAT pathway belong in the pathology of Spondyloarthritis (SpA)? (10 min) Dr Fernando Sommerfleck
  • Deep Dive into SpA: Is there a place for JAK inhibitors? (30 min) Dr Rodrigo Luppino – Brazil
  • Answers to the questions you’re dying to ask! (15 min) Dr Fernando Sommerfleck / Dr Rodrigo Luppino/ all
  • Guidelines for the treatment of Psoriatic Arthritis. Dr. Enrique Soriano (20 min)
  • Axial PsA: are we missing something? Dr. Xenofon Baraliakos (20 min)
  • Q&A (20 min)
  • Moderator: Dra. Lorena Brance – Argentina
  • Speaker: Dr. Esteban Jodar (45 min) España
  • Q&A (15 min)